This inventor holds 2 USPTO granted patents. Top assignee: Novo Nordisk A/s. Active years: 2001-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Prague, CZ (2001)
- Praha, CZ (2003)
Company Filing History:
Years Active: 2001-2003
Title: Inventor Spotlight: Silhánková Alexandra
Introduction
Silhánková Alexandra, based in Praha, Czech Republic, is an innovative inventor with a keen focus on advancements in the field of medicinal chemistry. He has contributed significantly to the scientific community through his impressive portfolio of patents, standing out as a notable figure in pharmaceutical research.
Latest Patents
Silhánková holds two notable patents, which reflect his expertise in the development of novel therapeutic agents. His latest inventions include "N-substituted azaheterocyclic carboxylic acids and their use" and "N-substituted azaheterocyclic carboxylic acids and esters thereof." These patents describe innovative compounds that serve as potential treatments for conditions characterized by pain and inflammation, particularly those involving C-fibers that elicit neurogenic pain or inflammation. The applications highlight not only the compounds themselves but also methods for their preparation and various compositions utilizing these novel substances.
Career Highlights
Silhánková has carved a niche for himself in the biopharmaceutical industry, currently working at Novo Nordisk A/S. His role is pivotal in pursuing innovative research aimed at improving therapeutic outcomes for patients battling chronic pain and inflammatory disorders. His contributions are integral to the company's mission of advancing healthcare solutions.
Collaborations
Collaboration plays a vital role in Silhánková's work, enriching the research environment in which he operates. Some of his notable colleagues include Florenzio Zaragossa Dörwald and Rolf Hohlweg, with whom he has worked closely to bring groundbreaking ideas to fruition. Together, they push the envelope in drug discovery and development.
Conclusion
As a prominent inventor, Silhánková Alexandra continues to make significant strides in pharmaceutical innovations. With his specialized knowledge and collaborative efforts, he is well-positioned to influence the future of pain management and inflammation treatment. His patents not only showcase his inventiveness but also reflect his commitment to enhancing patient care through science and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
